Re-imagining Vaccine Manufacturing To Address Global Health Challenges

In the last decade, biopharmaceutical industries have had to mobilize quickly in response to pandemics. Developing vaccines and manufacturing large doses in an emergency is often constrained by existing platforms and facility set ups. Vaccine manufacturing needs to evolve to tackle future global health challenges. Watch this webinar to learn more.